DOI:
10.1055/s-00034924
Nuklearmedizin - NuclearMedicine
LinksClose Window
References
Dauer LT, Williamson MJ, Humm J. et al.
Radiation safety considerations for the use of 223RaCl2 DE in men with castration-resistant prostate cancer.
Health Phys 2014;
106: 494-504.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.